Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

WESTLAKE CORP Director's Dealing 2014

Mar 3, 2014

30551_dirs_2014-03-03_c25529f5-4621-4b44-bd81-72023ce31e47.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: WESTLAKE CHEMICAL CORP (WLK)
CIK: 0001262823
Period of Report: 2014-02-28

Reporting Person: RILEY H JOHN JR (Director)

Non-Derivative Transactions

Date Security Code Shares Price A/D Holdings After Ownership
2014-02-28 Common Stock M 3549 $24.51 Acquired 12355 Direct
2014-02-28 Common Stock M 3826 $20.825 Acquired 16181 Direct
2014-02-28 Common Stock S 7375 $134.7047 Disposed 8806 Direct

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2014-02-28 Employee Option (right to buy) $24.51 M 3549 Disposed 2019-08-20 Common Stock (3549) Direct
2014-02-28 Employee Option (right to buy) $20.825 M 3826 Disposed 2018-08-25 Common Stock (3826) Direct

Footnotes

F1: The stock options are exercisable in three installments of 33%, 33% and 34% on August 20, 2010, 2011 and 2012, respectively.

F2: The stock options are exercisable in three installments of 33%, 33% and 34% on August 15, 2009, 2010 and 2011, respectively.

F3: In accordance with the Securities and Exchange Commission's No Action Letter dated June 25, 2008, we have aggregated the sales that occurred on February 28, 2014 for ease of reporting. The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions ranging from $134.678 to $134.84, inclusive. The reporting person undertakes to provide to Westlake Chemical Corporation, any security holder of Westlake Chemical Corporation or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in this footnote (3) to this Form 4.